Correlation Between Checkpoint Therapeutics and Gamida Cell
Can any of the company-specific risk be diversified away by investing in both Checkpoint Therapeutics and Gamida Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Checkpoint Therapeutics and Gamida Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Checkpoint Therapeutics and Gamida Cell, you can compare the effects of market volatilities on Checkpoint Therapeutics and Gamida Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Checkpoint Therapeutics with a short position of Gamida Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Checkpoint Therapeutics and Gamida Cell.
Diversification Opportunities for Checkpoint Therapeutics and Gamida Cell
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Checkpoint and Gamida is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Checkpoint Therapeutics and Gamida Cell in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gamida Cell and Checkpoint Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Checkpoint Therapeutics are associated (or correlated) with Gamida Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gamida Cell has no effect on the direction of Checkpoint Therapeutics i.e., Checkpoint Therapeutics and Gamida Cell go up and down completely randomly.
Pair Corralation between Checkpoint Therapeutics and Gamida Cell
If you would invest 335.00 in Checkpoint Therapeutics on December 30, 2024 and sell it today you would earn a total of 69.00 from holding Checkpoint Therapeutics or generate 20.6% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Checkpoint Therapeutics vs. Gamida Cell
Performance |
Timeline |
Checkpoint Therapeutics |
Gamida Cell |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Checkpoint Therapeutics and Gamida Cell Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Checkpoint Therapeutics and Gamida Cell
The main advantage of trading using opposite Checkpoint Therapeutics and Gamida Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Checkpoint Therapeutics position performs unexpectedly, Gamida Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gamida Cell will offset losses from the drop in Gamida Cell's long position.Checkpoint Therapeutics vs. Mustang Bio | Checkpoint Therapeutics vs. Reviva Pharmaceuticals Holdings | Checkpoint Therapeutics vs. Fortress Biotech Pref | Checkpoint Therapeutics vs. Kodiak Sciences |
Gamida Cell vs. BioLineRx | Gamida Cell vs. Ardelyx | Gamida Cell vs. Lexicon Pharmaceuticals | Gamida Cell vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |